Le Wang
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Papers in
- Epidemiology 25
- Liver Disease Diagnosis and Treatment 6
- Hepatitis B Virus Studies 5
- Respiratory viral infections research 4
- Pneumonia and Respiratory Infections 3
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Lingbin Du (13 shared papers)Youqing Wang (9 shared papers)Bin Lu (3 shared papers)Zongping Wang (2 shared papers)Mengjie He (1 shared paper)Min Dai (12 shared papers)Jufang Shi (9 shared papers)Mengchuan Zhao (4 shared papers)
- Journals
- JMIR Public Health and Surveillance (4 papers)Frontiers in Oncology (3 papers)Frontiers in Public Health (3 papers)Medicine (2 papers)BMC Infectious Diseases (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Le Wang
80 papers receiving 1.3k citations
Le Wang's Hit Papers
Peers
Comparison fields: 5 of 119
- Pulmonary and Respiratory Medicine 333
- Cancer Research 127
- Oncology 201
- Epidemiology 153
- Pharmacology 40
Countries citing papers authored by Le Wang
This map shows the geographic impact of Le Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Wang more than expected).
Fields of papers citing papers by Le Wang
This network shows the impact of papers produced by Le Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Wang. The network helps show where Le Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Le Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019 Hit paper breakdown → | 2022 | 424 |
| 2 | 2019 | 77 | |
| 3 | 2021 | 47 | |
| 4 | 2018 | 44 | |
| 5 | 2016 | 34 | |
| 6 | 2014 | 31 | |
| 7 | 2017 | 30 | |
| 8 | 2022 | 29 | |
| 9 | 2023 | 27 | |
| 10 | 2018 | 25 | |
| 11 | 2020 | 24 | |
| 12 | 2013 | 24 | |
| 13 | 2019 | 22 | |
| 14 | 2019 | 22 | |
| 15 | 2013 | 22 | |
| 16 | 2018 | 22 | |
| 17 | 2022 | 21 | |
| 18 | 2023 | 19 | |
| 19 | 2016 | 17 | |
| 20 | 2017 | 16 |
About Le Wang
Le Wang is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Infectious Diseases, having authored 88 papers that have together received 1.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Colorectal Cancer Screening and Detection (6 papers), Global Cancer Incidence and Screening (6 papers), Lung Cancer Treatments and Mutations (6 papers), Hepatitis B Virus Studies (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Respiratory viral infections research (4 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (333 citations), Cancer Research (127 citations), Oncology (201 citations), Epidemiology (153 citations) and Pharmacology (40 citations). Le Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lingbin Du, Youqing Wang, Bin Lu, Zongping Wang, Mengjie He, Min Dai, Jufang Shi, Mengchuan Zhao, Zhishan Feng and Guoyu Pan. Their work appears in journals such as JMIR Public Health and Surveillance, Frontiers in Oncology, Frontiers in Public Health, Medicine and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.